Bart A. van den Berg
Founder at VenGen BV
Bart A. van den Berg active positions
| Companies | Position | Start | End |
|---|---|---|---|
VenGen BV
 VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Founder | 01/07/2001 | - |
| Private Equity Investor | 01/07/2001 | - | |
| Director of Investments | 01/07/2001 | 22/07/2010 | |
Diagnoptics Technologies BV
 Diagnoptics Technologies BV Medical SpecialtiesHealth Technology DiagnOptics Technologies BV develops and manufactures diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. The firm’s AGE reader diagnoses and assesses the risk of cardiovascular, diseases through measuring tissue accumulation of AGEs. The company was founded by Reindert Graaff and Andries J. Smit in 2003 and is headquartered in Groningen, the Netherlands. | Chief Executive Officer | 01/06/2004 | - |
Career history of Bart A. van den Berg
Training of Bart A. van den Berg
| University of Tilburg | Graduate Degree |
Statistics
International
| Netherlands | 4 |
Operational
| Founder | 1 |
| Director of Investments | 1 |
| Private Equity Investor | 1 |
Sectoral
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
VenGen BV
VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Finance |
Diagnoptics Technologies BV
Diagnoptics Technologies BV Medical SpecialtiesHealth Technology DiagnOptics Technologies BV develops and manufactures diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. The firm’s AGE reader diagnoses and assesses the risk of cardiovascular, diseases through measuring tissue accumulation of AGEs. The company was founded by Reindert Graaff and Andries J. Smit in 2003 and is headquartered in Groningen, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Bart A. van den Berg
- Experience